Hua Yao Pharmaceutical: The production and operation are normal, and there is no significant information that should be disclosed but has not been disclosed.

On January 13th, Jinshi Data News, Harbin Pharmaceutical Co., Ltd. issued a notice on abnormal changes. After the company’s self-inspection, the current production and operation of the company are normal, and there have been no major changes in the internal and external operating environment. There are no major issues affecting the abnormal fluctuation of the company’s stock trading price and no significant information that should have been disclosed but not disclosed.